Concord Healthcare Group Co., Ltd. released its Monthly Return for Equity Issuers covering the period ended 30 April 2026. Key points are as follows:

• Issued Share Capital Unchanged – H-shares: 313.87 million outstanding, unchanged from the previous month. – Domestic shares: 469.79 million, also unchanged. – Combined issued share capital stood at 783.66 million shares, with no treasury shares reported.

• Authorised/Registered Capital Mirror Issued Figures – H-share and domestic-share authorisations were identical to issued totals, each carrying a par value of RMB 1.00.

• Public Float Compliance – The company confirmed that its H-share public float met the Main Board’s Initial Prescribed Threshold of 25% as of 30 April 2026.

• No Dilutive Instruments or Corporate Actions – The filing recorded no share options, warrants, convertible securities, or other agreements that could affect the share count. – No share repurchases, cancellations, or treasury share movements occurred during the month.

• Filing Details – Submission date: 07 May 2026. – Document signed by Company Secretary Pan Lichen.

The absence of share movements indicates a stable capital structure over the reporting month, while confirmation of public float sufficiency underscores ongoing compliance with Hong Kong listing requirements.